2013 EU Biotechnology Conference2013 EU Biotechnology Conference2013 EU Biotechnology Conference
Share:          

Education Details

Register Now!

About This Two-Day Education Conference

Biotechnology is a highly specialised segment within the pharmaceutical space.  In recent years biotechnology has evolved to lead the industry standard in medicines manufacturing by implementing cheaper and faster processes for producing drugs.  Biotechnology has similarly expanded to include new and diverse sciences and with the advent of biosimilars, these medicines are becoming more accessible for patients globally. In parallel to this expansion, the concept of biotechnology also encompasses a wide range of procedures.  

The biotech industry in transition faces many challenges, the most fundamental one being how to successfully optimise and scale-up manufacturing processes and achieve successful commercial scale manufacturing. This requires years of experience and in-depth specialised know-how.

This two-day, must-attend, education conference will use case studies to explore current technologies, regulatory requirements and will provide you with techniques for the evaluation and implementation of cutting-edge technologies. In-depth discussion will focus on cost-effective, flexible, sustainable manufacturing facilities design and implementation.

The Programme will include seminars, case studies, workshops and Q&A sessions.

View the Conference Agenda ( 170 KB)
 

View the Conference Flyer ( 107 KB)

 

Conference Programme Committee

Chair: Dr. David Estapé, Technology Manager Biotech, M+W Germany GmbH, Germany

Co-Chair: Dr. Steven Davy, PhD, Specialist Active Products & Utility, NNE Pharmaplan, Denmark

Miriam Monge, Vice President Sales & Marketing, Biopharm Services Ltd, France 

Philippe Robin, Senior Consultant, Pharmacy, Jacobs, France 

Bruce Williams, Director, Williams Process Limited, UK

Dave Wolton, Biotechnology Consultant, PM Group, Ireland

Keynote Speaker

Britt Petty, Director MEF, Biogen Idec, Denmark

Education Sessions include:

Two sessions discussing the recent updates to the ISPE Guides*:

* Complimentary Guide of Your Choice (electronic download) included with registration

Sessions on Facility Design examining:

  • Facility design and layout
  • Maximising facility throughput
  • Buffer supply
  • Containment
  • Migration from stainless steel to disposable systems

Sessions focusing on the recent development in Biosimilars:

  • Pharmacopeia
  • Biosimilar manufacturing processes

Case Studies on Enabling and New Technologies:

  • Process economics/improvements
  • SU/Disposable component technologies
  • Automation of process activities and functions
  • New manufacturing technologies

A look at Harmonised Global Regulatory Environment:

  • Quality by Design
  • Common Regulatory Standards
  • Process Validation
  • Quality Systems

Plant Tours

During the afternoon of day one, delegates will have the opportunity to visit a state-of-the-art site to see in action the concepts presented throughout the conference.

(Places are limited for each site and will be allocated on a first-come, first-served basis.)

Who Should Attend?

This conference will be of value to mid- and senior level professionals from the pharmaceutical and biopharmaceutical industry, suppliers and regulators, process development scientists, technology transfer managers, manufacturing managers, engineers, quality assurance professionals, quality control professionals, risk assessment professionals and academia.

Thank you to our Top Tier Sponsors

  • Pinnacle Sponsor
  • Pinnacle Sponsor
  • Pinnacle Sponsor
  • Follow ISPE

    ISPE Twitter Page ISPE Facebook Page ISPE LinkedIn Page